Position Statement on Secukinumab in the Management of Plaque Psoriasis: The Malaysian Perspective

Position Statement on Secukinumab in the Management of Plaque Psoriasis: The Malaysian Perspective

Show other versions (1)

Psoriasis is a chronic inflammatory skin disease affecting nearly 10% of dermatologic patients in Malaysia. Treatment options include topical agents and phototherapy as well as nonbiologic and biologic systemic therapy. Mild psoriasis can often be managed with topical agents. However, managing moder...

Full description

Bibliographic Details
Main Authors: Chan, L.C (Author), Ch'Ng, C.C (Author), Heng, A. (Author), Johar, A. (Author), Mohd Safdar, N.A (Author), Muniandy, P. (Author), Taib, T. (Author), Tan, W.C (Author), Tey, K.E (Author), Thevarajah, S. (Author)
Format: Article
Language:English
Published: Hindawi Limited 2019
Subjects:
biological therapy
Dermatology Life Quality Index
disease severity
drug safety
human
Malaysia
nail psoriasis
patient monitoring
phototherapy
physician global assessment
Psoriasis Area and Severity Index
psoriasis vulgaris
psoriatic arthritis
pustulosis palmoplantaris
Review
scalp psoriasis
scoring system
secukinumab
treatment failure
treatment response
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items